Potential Winner Of The First NASH Battle

|
About: Madrigal Pharmaceuticals, Inc. (MDGL), Includes: AGN, GALT, GNFT, ICPT
by: Mehdi Mehdiyev
This article is exclusive for subscribers.
Mehdi Mehdiyev
Long/Short Equity, Deep Value, Value, Growth
Summary

NASH is an impregnable fortress for many pharma companies.

The battle for NASH has entered an important stage.

First potential players in the multi-billion-dollar market.

Who is the first wave winner?

Over the past years, many companies have struggled to offer the first NASH cure to the market. Billions of investments have been spent on the study and possible treatments of this complex disease.

So far,